Angiodynamic Inc [ANGO] stock is trading at $12.61, up 2.69%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The ANGO shares have gain 5.61% over the last week, with a monthly amount glided 13.30%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Angiodynamic Inc [NASDAQ: ANGO] stock has seen the most recent analyst activity on July 16, 2025, when Lake Street initiated its Buy rating and assigned the stock a price target of $24. Previously, Oppenheimer upgraded its rating to Outperform on April 05, 2024, and kept the price target unchanged to $12. On September 25, 2023, H.C. Wainwright initiated with a Buy rating and assigned a price target of $19 on the stock. Raymond James downgraded its rating to a Outperform and decreased its price target to $13 on April 17, 2023. Canaccord Genuity upgraded its rating to a Buy and raised its price target to $37 on October 15, 2021. In a note dated November 25, 2020, Raymond James upgraded an Strong Buy rating on this stock but restated the target price of $18.
Angiodynamic Inc [ANGO] stock has fluctuated between $6.63 and $13.50 over the past year. Currently, Wall Street analysts expect the stock to reach $18 within the next 12 months. Angiodynamic Inc [NASDAQ: ANGO] shares were valued at $12.61 at the most recent close of the market. An investor can expect a potential return of 42.74% based on the average ANGO price forecast.
Analyzing the ANGO fundamentals
Angiodynamic Inc [NASDAQ:ANGO] reported sales of 300.72M for the trailing twelve months, which represents a growth of 12.18%. Gross Profit Margin for this corporation currently stands at 0.54% with Operating Profit Margin at -0.12%, Pretax Profit Margin comes in at -0.11%, and Net Profit Margin reading is -0.11%. To continue investigating profitability, this company’s Return on Assets is posted at -0.12, Equity is -0.17 and Total Capital is -0.19.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 12.33 points at the first support level, and at 12.04 for the second support level. However, for the 1st resistance point, the stock is sitting at 12.84, and for the 2nd resistance point, it is at 13.06.
Ratios To Look Out For
For context, Angiodynamic Inc’s Current Ratio is 2.29. Further, the Quick Ratio stands at 1.38, while the Cash Ratio is 0.57. Considering the valuation of this stock, the price to sales ratio is 1.73, the price to book ratio is 2.92.
Transactions by insiders
Recent insider trading involved Weiss Lawrence T, SVP, Chief Legal Officer, that happened on Oct 21 ’25 when 10000.0 shares were purchased. EVP and CFO, Trowbridge Stephen A completed a deal on Oct 13 ’25 to buy 890.0 shares. Meanwhile, President and CEO Clemmer James C bought 10000.0 shares on Oct 09 ’25.
